TEHRAN – The health ministry and the National Immunization Technical Advisory Group (NITAG), with technical support from the World Health Organization (WHO) Country Office, have carried out a study applying WHO New Vaccine Introduction Prioritization and Sequencing Toolkit (NVI-PST) to help establish a transparent, evidence-based roadmap for introducing new vaccines over 2025–2030.
Iran Develops Roadmap for New Vaccine Introduction with WHO Support
Iran's health ministry and the National Immunization Technical Advisory Group are studying the WHO's New Vaccine Introduction Prioritization and Sequencing Toolkit to create a roadmap for new vaccine introductions from 2025 to 2030. This initiative, supported by the WHO, aims to ensure a transparent and evidence-based approach to vaccination in Iran.
👥 Key Players
📰 What Happened
Iran's health ministry and NITAG are developing a roadmap for introducing new vaccines from 2025 to 2030, utilizing WHO's toolkit for prioritization. This initiative aims to create a transparent and evidence-based vaccination strategy.
- The roadmap will guide vaccine introduction over the next five years.
- WHO's support is crucial for ensuring the roadmap is based on global best practices.
💡 Why It Matters
📚 Background
Vaccination is a critical component of public health, and the introduction of new vaccines can significantly reduce disease burden. Iran has faced challenges in its healthcare system, making such initiatives essential.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%